as on January 28, 2026 at 9:40 pm IST
Day's Low
Day's High
0.37%
Downside
5.16%
Upside
52 Week's Low
52 Week's High
22.65%
Downside
252.58%
Upside
Check Atara Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$38.1M
EPS (TTM)
1.3825
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
1.85
Industry PE ratio
-2.8168481375358168
PEG Ratio
0EBITDA
44.9M
Revenue (TTM)
151.9M
Profit Margin
15.40%
Return On Equity TTM
-2014.86%
Track how Atara Biotherapeutics Inc P/E has moved over time to understand its valuation trends.
Atara Biotherapeutics Inc in the last 5 years
Lowest (-115.97x)
December 31, 2021
Industry (-2.82x)
January 28, 2026
Today (1.85x)
January 28, 2026
Highest (5.28x)
September 30, 2025
Today’s Price to Earnings Ratio: 1.85x
Compare market cap, revenue, PE, and other key metrics of Atara Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $38.1M | -98.83% | 1.85 | 15.40% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Atara Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atara Biotherapeutics Inc investment value today
Current value as on today
₹70,926
Returns
Returns from Atara Biotherapeutics Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Based on 13 analysts
61.54%
Buy
30.77%
Hold
7.69%
Sell
Based on 13 analysts, 61.54% of analysts recommend a 'BUY' rating for Atara Biotherapeutics Inc. Average target price of $8.67
Get share price movements and forecasts by analysts on Atara Biotherapeutics Inc.
What analysts predicted
37.37%UPSIDE
Target Price
$8.67
Current Price
$5.43
Analyzed by
13 Analysts
Target
$8.67
Atara Biotherapeutics Inc target price $8.67, a slight upside of 37.37% compared to current price of $5.43. According to 13 analysts rating.
Investment in Atara Biotherapeutics Inc Shares on INDmoney has grown by 5000.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:5000.00% versus previous 30 day period
Search interest for Atara Biotherapeutics Inc Stock has increased by 1216% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1216% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, ATRA stock has moved up by 20.9%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 81.8%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 125.2%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 38.01M → -4.30M (in $), with an average decrease of 187.0% per quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 98.14M → 3.45M (in $), with an average decrease of 81.2% per quarter
| Organisation | Atara Biotherapeutics Inc |
| Headquarters | 1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320 |
| Industry | Health Technology |
| CEO | Dr. Anhco Nguyen Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Anhco Nguyen Ph.D. | President, CEO & Director |
Ms. Yanina Grant-Huerta | Chief Accounting Officer & Principal Accounting Officer |
Alex Chapman | Vice President of Corporate Communications & Investor Relations |
Mr. John Chao | Head of Legal |
Mr. Jim Sesic | Senior Vice President of Regulatory Affairs |
Atara Biotherapeutics Inc share price today is $5.43 as on . Atara Biotherapeutics Inc share today touched a day high of $5.71 and a low of $5.41.
Atara Biotherapeutics Inc share touched a 52 week high of $19.15 on and a 52 week low of $4.2 on . Atara Biotherapeutics Inc stock price today i.e. is trending at $5.43,which is 71.64% down from its 52 week high and 29.29% up from its 52 week low.
Atara Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Atara Biotherapeutics Inc (ATRA) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Atara Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atara Biotherapeutics Inc share’s latest price of $5.43 as on January 28, 2026 at 9:40 pm IST, you will get 1.8416 shares of Atara Biotherapeutics Inc. Learn more about
fractional shares .
Atara Biotherapeutics Inc stock has given -98.83% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?